All lobbying filings

AVENUE SOLUTIONS

Lobbying for JAZZ PHARMACEUTICALS, INC. · Specialty pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $50,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 4

HR 946
ORPHAN Cures Act
S 1862
ORPHAN Cures Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HCONRES 14
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appro…

Lobbying activity 1

Health Issues

Drug safety, prescription drug abuse, value of prescription drugs; H.R. 946/S. 1862, Orphan Cures Act; Health care issues in H.R.1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); Issues related to drug pricing

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.